Cargando…
The embryological basis of subclinical hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomeric proteins, the commonest being MYBPC3 encoding myosin-binding protein C. It is characterised by left ventricular hypertrophy but there is an important pre-hypertrophic phenotype with features including crypts, abnormal mitral leaf...
Autores principales: | Captur, Gabriella, Ho, Carolyn Y., Schlossarek, Saskia, Kerwin, Janet, Mirabel, Mariana, Wilson, Robert, Rosmini, Stefania, Obianyo, Chinwe, Reant, Patricia, Bassett, Paul, Cook, Andrew C., Lindsay, Susan, McKenna, William J., Mills, Kevin, Elliott, Perry M., Mohun, Timothy J., Carrier, Lucie, Moon, James C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914973/ https://www.ncbi.nlm.nih.gov/pubmed/27323879 http://dx.doi.org/10.1038/srep27714 |
Ejemplares similares
-
It's not just the mitral valve - abnormal motion of the whole aorto-mitral apparatus occurs in both overt and subclinical hypertrophic cardiomyopathy
por: Obianyo, Chinwe, et al.
Publicado: (2016) -
Myoarchitectural disarray of hypertrophic cardiomyopathy begins pre‐birth
por: Garcia‐Canadilla, Patricia, et al.
Publicado: (2019) -
Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015) -
CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015) -
Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy
por: Schlossarek, Saskia, et al.
Publicado: (2014)